Comparison of Vonoprazan Versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers Rebleeding After Successful Endoscopic Hemostasis: A Multicenter Randomized Noninferiority Trial.
Tanawat GeeratragoolUayporn KaosombatwattanaArpapun BoonchoteSuvikrom ChatthammanatNutchanun PreechakawinJompol SrichotAsawin SudcharoenPavapol SirisunhirunPanotpol TermsinsukManus RugivarodomJulajak LimsrivilaiMonthira ManeerattanapornNonthalee PausawasdiSomchai LeelakusolvongPublished in: Gastroenterology (2024)
In patients with high-risk PU bleeding, the efficacy of vonoprazan in preventing 30-day rebleeding was noninferior to intravenous PPI. (ClinicalTrials.gov, Number: NCT05005910).